GGrantIndex
← Leaderboards

Chonghui Cheng

Northwestern University At Chicago

$7,932,847
Attributed
$7,932,847
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,932,847 · 4

By mechanism

R01$4,477,681 · 3
R35$3,455,166 · 1

Top collaborators

No co-investigators on record.

Most similar at Northwestern University At Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsRna SplicingNeoplasm MetastasisRegulationAlternative SplicingMolecularMesenchymalProtein IsoformsCd44 GeneDevelopmental ProcessSignal TransductionEpithelialPhenotypeExonsMrna PrecursorGenesMammalsMessenger RnaMalignant Breast NeoplasmTranscriptTumorInsightMediatingBinding

Grant awards (24)

Mechanisms of tumor cell clustering in breast cancer metastasis$462,861
R01 · FY2025 · CA · contact PI
Regulation and consequences of cryptic splicing$444,960
R35 · FY2025 · GM · contact PI
Regulation and consequences of cryptic splicing$469,923
R35 · FY2024 · GM · contact PI
Mechanisms of tumor cell clustering in breast cancer metastasis$439,719
R01 · FY2024 · CA · contact PI
Mechanisms of tumor cell clustering in breast cancer metastasis$462,861
R01 · FY2023 · CA · contact PI
Regulation of alternative splicing during epithelial-mesenchymal transition$400,000
R35 · FY2023 · GM · contact PI
Regulation of alternative splicing during epithelial-mesenchymal transition$400,000
R35 · FY2023 · GM · contact PI
R35 Administrative Supplements for Equipment: Regulation of alternative splicing during epithelial-mesenchymal transition$75,426
R35 · FY2023 · GM · contact PI
R35 Admin Diversity Supplement: Regulation of alternative splicing during epithelial-mesenchymal transition$65,794
R35 · FY2023 · GM · contact PI
Regulation of alternative splicing during epithelial-mesenchymal transition$400,000
R35 · FY2022 · GM · contact PI
Regulation of alternative splicing during epithelial-mesenchymal transition$400,000
R35 · FY2021 · GM · contact PI
Regulation of alternative splicing during epithelial-mesenchymal transition$400,000
R35 · FY2020 · GM · contact PI
Regulation of alternative splicing during epithelial-mesenchymal transition$399,063
R35 · FY2019 · GM · contact PI
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis$328,888
R01 · FY2018 · CA · contact PI
Mechanisms of hnRNPM in Alternative Splicing Regulation During EMT$301,150
R01 · FY2018 · GM · contact PI
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis$328,888
R01 · FY2017 · CA · contact PI
Mechanisms of hnRNPM in Alternative Splicing Regulation During EMT$301,150
R01 · FY2017 · GM · contact PI
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis$301,150
R01 · FY2016 · CA · contact PI
Mechanisms of hnRNPM in Alternative Splicing Regulation During EMT$301,150
R01 · FY2016 · GM · contact PI
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis$21,588
R01 · FY2016 · CA · contact PI
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis$320,588
R01 · FY2015 · CA · contact PI
Mechanisms of hnRNPM in Alternative Splicing Regulation During EMT$293,550
R01 · FY2015 · GM · contact PI
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis$320,588
R01 · FY2014 · CA · contact PI
Mechanisms of hnRNPM in Alternative Splicing Regulation During EMT$293,550
R01 · FY2014 · GM · contact PI